- DL Recommends: Hold
- This Stock is recommended "Hold" this company is expected to perform at the same pace as comparable companies or in-line with the market.
Key Fundamentals of CADILA HEALTHCARE
- Sector:
- PHARMA
- Category:
- Large Cap
Profit after Tax | 1848.80 | Book Value | 114.08 |
PE Ratio | 14.62 | Institutions Holding | 199 |
Market Capitalization | 27026.80 | ||
Debt to Equity Ratio | 0.69 | EBIDTA | 2374.50 |
Dividend Yield | 1.32 | Promoter's Pledge (%) | 0.00 |
Correction Levels to Buy(From recent high)
Recent High | 268.35 |
10% Correction | 241.52 |
20% Correction | 214.68 |
30 % Correction | 187.85 |
Strong Support Technical Buy Levels(Monthly & Weekly Levels)
Week 3 Level | 234.50 |
Week 4 Level, Month 1 Level | 218.50 |
Week 16 Level, Month 4 Level | 207.00 |
Chart
We recomend to use Weekly and Monthly charts. Daily charts are also given which are used for exits. We donot recomend daily/intraday minuite, hourly charts. The major levels come from weekly and monthly charts which the FII, fund managers usually use for entry and profit exit.
Exchange Symbol | CADILAHC (NSE) |
---|---|
Sector | PHARMA |
Current Price * (Rs.) | 264.00 |
Face Value (Rs.) | 1 |
52 Week High (Rs.) | 359.75 (16-Jan-19) |
52 Week Low (Rs.) | 206.50 (22-Aug-19) |
Life Time high (Rs.) | 560.00 (10-Jul-17) |
Life Time low (Rs.) | 5.53 (25-Jul-01) |
Average Daily Movement [ADM] | 8.55 |
Average Volume [20 days] | 3597790 |
Average Value [1 Year] | 45.72 (Cr) |
1 Month Return (%) | 17.46 |
Consolidated FY 15-16 PE Ratio | 14.62 |
Consolidated Trailing PE Ratio | 19.43 |
Standalone FY 15-16 PE Ratio | 16.87 |
Standalone Trailing PE Ratio | 20.28 |
Book Value | 114.08 |
Market Cap | 27026.80 (Cr) |
% of Promoter holding pledged | 0 |
Get to know the FUTURE CADILA share price & overview of FUTURE CADILA, 52 week highs/lows & lifetime highs/lows, average volume, adm & 1 month return %.